PF4 Promotes Platelet Production and Lung Cancer Growth
Ferdinando Pucci,Steffen Rickelt,Andita P Newton,Christopher Garris,Ernesto Nunes,Charles Evavold,Christina Pfirschke,Camilla Engblom,Mari Mino-Kenudson,Richard O Hynes,Ralph Weissleder,Mikael J Pittet
DOI: https://doi.org/10.1016/j.celrep.2016.10.031
2016-11-08
Abstract:Co-option of host components by solid tumors facilitates cancer progression and can occur in both local tumor microenvironments and remote locations. At present, the signals involved in long-distance communication remain insufficiently understood. Here, we identify platelet factor 4 (PF4, CXCL4) as an endocrine factor whose overexpression in tumors correlates with decreased overall patient survival. Furthermore, engineered PF4 over-production in a Kras-driven lung adenocarcinoma genetic mouse model expanded megakaryopoiesis in bone marrow, augmented platelet accumulation in lungs, and accelerated de novo adenocarcinogenesis. Additionally, anti-platelet treatment controlled mouse lung cancer progression, further suggesting that platelets can modulate the tumor microenvironment to accelerate tumor outgrowth. These findings support PF4 as a cancer-enhancing endocrine signal that controls discrete aspects of bone marrow hematopoiesis and tumor microenvironment and that should be considered as a molecular target in anticancer therapy.